Nuwellis, Inc. (NASDAQ:NUWE – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 195,586 shares, a growth of 118.9% from the October 15th total of 89,357 shares. Approximately 36.8% of the company’s shares are sold short. Based on an average daily trading volume, of 3,723,204 shares, the short-interest ratio is presently 0.1 days.
Nuwellis Price Performance
Shares of NASDAQ NUWE traded down $0.18 during midday trading on Monday, hitting $4.71. 4,439 shares of the company’s stock were exchanged, compared to its average volume of 337,937. The firm has a market cap of $2.55 million, a P/E ratio of -0.00 and a beta of 0.03. Nuwellis has a twelve month low of $2.52 and a twelve month high of $1,556.07. The stock’s 50 day moving average price is $6.03 and its 200-day moving average price is $206.53.
Nuwellis (NASDAQ:NUWE – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($5.81) earnings per share for the quarter, topping the consensus estimate of ($122.85) by $117.04. Nuwellis had a negative net margin of 150.50% and a negative return on equity of 414.75%. The business had revenue of $2.21 million during the quarter, compared to the consensus estimate of $2.50 million.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on NUWE
Nuwellis Company Profile
Nuwellis, Inc. is a medical technology company focused on fluid management for patients with fluid overload. The company develops and markets the Aquadex SmartFlow system, which uses ultrafiltration to remove excess fluid and is used by healthcare professionals in hospital settings. Aquadex includes a device and disposable components designed to support controlled fluid removal. It is intended for use in adults and children with fluid overload, including patients who may not respond adequately to diuretic therapy.
Further Reading
- Five stocks we like better than Nuwellis
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.
